Issues and missed opportunities in lymph node assessment after neoadjuvant chemotherapy

Area of Science:

• Oncology
• Pathology
• Immunology

Background:

• Axillary lymph node assessment after neoadjuvant chemotherapy (NACT) is critical for breast cancer prognosis and management.
• Current methods lack standardization and focus narrowly on residual tumor burden, neglecting nuanced changes within lymph nodes.
• The increasing use of NACT with immunotherapy necessitates a deeper understanding of lymph node responses.

Purpose of the Study:

• To review current axillary lymph node assessment strategies in breast cancer post-NACT.
• To explore novel, more granular approaches to lymph node evaluation.
• To highlight the potential for improved patient stratification through detailed pathological analysis.

Main Methods:

• Literature review of current and novel lymph node assessment techniques.
• Discussion of findings from multiple carcinoma studies applicable to breast cancer.
• Emphasis on translating research into clinical practice and reporting standards.

Main Results:

• Current lymph node assessment post-NACT is limited in scope.
• Emerging granular approaches offer potential for richer prognostic and predictive information.
• Understanding immunological and architectural changes in lymph nodes is crucial.

Conclusions:

• There is a need for standardized, more detailed pathological assessment of lymph nodes after NACT in breast cancer.
• Incorporating analysis of viable tumor percentage and immunological features could refine patient stratification.
• Further research and clinical validation are required to implement these advanced assessment methods.